Boston Scientific (BSX) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Boston Scientific (BSX) PT Raised to $21 at Leerink Partners Following Q1
April 29, 2015 8:57 AM EDTLeerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted its price target Boston Scientific (NYSE: BSX) price target of $21.00 (from $18.00) following Q1 results and solid 2015 outlook.
Antalffy commented, "Over the last two years, BSX's turnaround story has steadily played out, with new management delivering... More
